BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21232524)

  • 1. Pathogenesis of nonmelanoma skin cancers in organ transplant recipients.
    Athar M; Walsh SB; Kopelovich L; Elmets CA
    Arch Biochem Biophys; 2011 Apr; 508(2):159-63. PubMed ID: 21232524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
    Bangash HK; Colegio OR
    Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
    Gluck M; Hodak E; Davidovici B
    Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
    Kovach BT; Sams HH; Stasko T
    Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
    Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ transplantation and skin cancer: basic problems and new perspectives.
    Hofbauer GF; Bouwes Bavinck JN; Euvrard S
    Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Leblanc KG; Hughes MP; Sheehan DJ
    Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic aspects of the pathogenesis and prevention of non-melanoma skin cancer in solid organ transplant recipients: a review.
    Perez HC; Benavides X; Perez JS; Pabon MA; Tschen J; Maradei-Anaya SJ; Lopez L; Lozano E
    Int J Dermatol; 2017 Apr; 56(4):370-378. PubMed ID: 27868187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
    Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair.
    Kuschal C; Thoms KM; Schubert S; Schäfer A; Boeckmann L; Schön MP; Emmert S
    Exp Dermatol; 2012 Jan; 21(1):2-6. PubMed ID: 22151386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of new immunosuppressive drugs in nonmelanoma skin cancer in renal transplant recipients.
    Bernat-García J; Morales Suárez-Varela M; Vilata-Corell JJ; Marquina-Vila A; Pallardo L; Crespo J
    Actas Dermosifiliogr; 2014 Dec; 105(10):940-6. PubMed ID: 25062648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials.
    Chung EYM; Palmer SC; Strippoli GFM
    Transplantation; 2019 Jun; 103(6):1206-1215. PubMed ID: 31246934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
    Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solar ultraviolet radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs): an update.
    Reichrath J
    Adv Exp Med Biol; 2014; 810():253-71. PubMed ID: 25207370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
    Tessari G; Girolomoni G
    Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
    Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer of the head and neck region in solid organ transplant recipients.
    Ritter A; Bachar G; Feinmesser R; Shpitzer T; Popovtzer A; Rabinovics N
    Head Neck; 2019 Feb; 41(2):374-380. PubMed ID: 30549347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
    Herold M; Good AJ; Nielson CB; Longo MI
    Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.